JPRN-UMIN000002249招募中未知
FDG-PET for prediction of the efficacy of chemotherapy followed by chemoradiotherapy for Stage II/III esophageal cancer. - FDG-PET for prediction of the efficacy of chemoradiotherapy.
Osaka Medical Center for Cancer and Cardiovascular Diseases0 个研究点目标入组 30 人开始时间: 2009年7月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Esophageal cancer spreading to pharynx or stomach. 2)Simultaneous double cancers. 3)Previous radiotherapy against cancer of thoracic cavity. 4)Uncontrollable complicating disease. 5)Interstitial pneumonia, fibroid lung. 6)History of collagen disease. 7)Psychosis. 8)Active infection which should be treated. 9)HBs antigen positive. HCV positive, TPHA positive, HIV positive 10)Women during pregnancy or breast-feeding. Men expecting to have a child.
研究者
相似试验
已完成
不适用
Optimal Medical Therapy Estimated by FDG PET/CT in Myocardial SarcoidosisMyocardial sarcoidosisJPRN-UMIN000022996The Department of Cardiology, Nagoya University Graduate School of Medicine50
尚未招募
不适用
sefulness of FDG-PET/CT to predict the response after anti-PD-1 antibody in patients with previously treated advanced non-small cell lung cancer: a multi-institutional studyPreviously treated advanced non-small cell lung cancerJPRN-UMIN000031009Gunma University120
招募中
不适用
sefulness of FDG-PET/CT to predict the response after nivolumab in patients with previously treated advanced non-small cell lung cancerPreviously treated advanced non-small cell lung cancerJPRN-UMIN000020814Gunma30
未知
不适用
sefulness of FDG-PET/CT to predict the response after pembrolizumab in patients with PD-L1 positive advanced non-small cell lung canceradvanced non-small cell lung cancerJPRN-UMIN000026730Gunma University Hospital50
进行中（未招募）
不适用
se of the PET-Scan examination in the evaluation of the treatment of patients diagnosed with Head and Neck CancerScamous Cell- Carcinoma of Head and NeckNeoplasmsPositron Emission Tomography Computed TomographyC04.557.470.200.400E01.370.350.350.800.700.500RBR-9wwstdAC Camargo Cancer Center